Process for making sterile aripiprazole of desired mean particle size

Details for Australian Patent Application No. 2004284904 (hide)

Owner Bristol-Myers Squibb Company

Inventors Kim, Soojin; Kientzler, Donald; Gleeson, Margaret; Kiang, San

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004284904

PCT Pub. Number WO2005/041970

Priority 60/513,886 23.10.03 US

Filing date 20 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 20 May 2010

International Classifications

B01D 9/00 (2006.01) Crystallisation

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/041970 Priority application(s): WO2005/041970

20 May 2010 Application Accepted

  Published as AU-B-2004284904

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284912-Process for producing injectable gabapentin compositions

2004284893-Treatment of vascular bifurcations